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Synthetic biology is expected to change how we understand and engineer biological 
systems. Lying at the intersection of molecular biology, physics, and engineering, the 
applications of this exploding field will both draw from and add to many existing disci-
plines. In this perspective, the recent advances in synthetic biology towards the design of 
complex, artificial biological systems are discussed.
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the rise of synthetiC Biology
Several remarkable hurdles in the life sciences have been 
cleared during the last half of the 20th century, from 
the discovery of the structure of DNA in 1959, to the 
deciphering of the genetic code, the development of re-
combinant DNA techniques, and the mapping of the 
human genome. Scientists have routinely tinkered with 
genes for the last 30 years, even inserting a cold-water 
fish gene into wheat to improve weather resistance; 
thus, synthetic biology is by no means a new science. 
Synthetic biology is a means to harness the biosynthetic 
machinery of organisms on the level of an entire ge-
nome to make organisms do things in ways nature has 
never done before.
Synthetic biology, despite its long history, is still in the 
early stages of development. The first international con-
ference devoted to the field was held at M.I.T in June 
2004. The leaders sought to bring together “researchers 
who are working to design and build biological parts, 
devices, and integrated biological systems; develop 
technologies that enable such work; and place this sci-
entific and engineering research within its current and 
future social context” (Synthetic Biology 101, 2004). 
The field is growing quickly, as evidenced by the rapidly 
increasing number of genetic discoveries, the exploding 
number of research teams exploring the field, and the 
funding from government and industrial sources.
Akin to the descriptive-to-synthetic transformation of 
chemistry in the 1900s, biological synthesis forces scien-
tists to pursue a “man-on-the-moon” goal that demands 
they discard erroneous theories and compels scientists 
to solve problems not encountered in observation. Data 
contradicting a theory can sometimes be excluded for 
the sake of argument, but doing the same while build-
ing a lunar shuttle would be disastrous. Synthetic biol-
ogy comes at an important time; by creating analogous 
“man-on-the-moon” engineering goals in the form of
synthetic bioorganisms, it is similarly driving scientists 
towards a deeper level of understanding of biology.
appliCations of engineered   
organisMs
It is expected that advances in synthetic biology will 
create important advances in applications too diverse 
and numerous to imagine. Applications of bioengi-
neered microorganisms include detecting toxins in 
air and water, breaking down pollutants and danger-
ous chemicals, producing pharmaceuticals, repairing 
defective genes, targeting tumors, and more. In 2008, 
genomics pioneer Dr. Craig Venter secured a $600 bil-
lion grant from ExxonMobil to develop hydrocarbon-
producing microorganisms as an alternative to crude oil 
(Borrell 2009).
Scientists are engineering microbes to perform complex 
multi-step syntheses of natural products. Jay Keasling, a 
professor at the University of California, Berkeley, re-
cently demonstrated genetically engineered yeast cells 
(Saccharomyces cerevisiae) that manufacture the imme-
diate precursor of artemisinin, a malarial drug widely 
used in developing countries (Ro et al, 2006). Before, 
this compound was chemically extracted from the sweet 
wormwood herb.  Since the extraction is expensive and 
the wormwood herb is prone to drought, the availabil-
ity of the drug is reduced in poorer countries. Once the 
engineered yeast cells were fine-tuned to produce high 
amounts of the artemisinin precursor, the compound 
was made quickly and cheaply. This same method could 
be applied to the mass-production of other drugs cur-
rently limited by natural sources, such as anti-HIV drug 
prostratin and anti-cancer drug taxol (Tucker & Zilin-
skas, 2006).
The most far-sighted effort in synthetic biology is the 
drive towards standardized biological parts and circuits. 
Just as other engineering disciplines rely on parts that are 
well-described and universally used — like transistors 
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and resistors — biology needs a tool box of standard-
ized genetic parts with characterized performance. The 
Registry of Standard Biological Parts comprises many 
short pieces of DNA that encode multiple functional 
genetic elements called “BioBricks” (Registry ofStan-
dard Biological Parts). In 2008, the Registry contained 
over 2000 basic parts comprised of sensors, input/out-
put devices, regulatory operators, and composite parts 
of varying complexity (Greenwald, 2005). The M.I.T. 
group made the registry free and public (http://parts.
mit.edu/) and has invited researchers to contribute to 
the growing library.
Some genetic parts code for a promoter gene that begins 
the transcription of DNA into mRNA, a repressor that 
codes a protein that blocks the transcription of another 
gene, a reporter gene that encodes a readout signal, a 
terminator sequence that halts RNA transcription, and 
a ribosome binding site that begins protein synthesis. 
The goal is to develop a discipline-wide standard and 
source for creating, testing, and combining BioBricks 
into increasingly complicated functions while reducing 
unintended interactions.
To date, BioBricks have been assembled into a few sim-
ple genetic circuits (McMillen & Collins, 2004). One 
creates a film of bacteria that is sensitive to light so it can 
capture images (Levskaya et al). Another operates as a 
type of battery, producing a weak electric current. Bio-
Bricks have been combined into logic gate devices that 
execute Boolean operations, such as AND, NOT, OR, 
NAND, and NOR. An AND operator creates an out-
put signal when it gets a biochemical signal from both 
inputs; an OR operator generates an output if it gets a 
signal from either input; and a NOT operator changes a 
weak signal into a strong one, and vice versa. This would 
allow cells to be small programmable machines whose 
operations can be controlled through light or various 
chemical signals (Atkinson et al, 2003).
Despite the enormous progress seen in the last five years 
and some highly publicized and heavily funded feats, 
the systematic and widespread design of biological sys-
tems remains a formidable task.
Current Challenges
standardization
Standards underlie engineering disciplines: measure-
ments, gasoline formulation, machining parts, and so 
on. Certain biotechnology standards have taken hold 
in cases such as protein crystallography and enzyme 
nomenclature, but engineered biology lacks a univer-
sal standard for most classes of functions and system 
characterization. One research group’s genetic toggle 
switch may work in a certain strain of Escherichia coli 
in a certain type of broth, while another’s oscillatory 
function may work in a different strain when cells are 
grown in supplemented minimal media (Endy, 2005). 
It is unclear whether the two biological functions can 
be combined despite the different operating parameters. 
The Registry of Standard Biological Parts and new Bio-
fab facilities have recently emerged to begin addressing 
this issue, and a growing consensus is emerging on the 




Drawing again from other engineering disciplines, and 
specifically from the semiconductor industry, synthetic 
biology must manage the enormous complexity of natu-
ral biological systems by abstraction hierarchies. After 
all, writing “code” with DNA letters is comparable to 
creating operating systems by inputing 1’s and 0’s. Lev-
els could be defined as DNA (genetic material), Parts 
(basic functions, such as a terminating sequence for an 
action), Devices (combinations of parts), and Systems 
(combinations of devices). Scientists should be able 
to work independently at each hierarchy level, so that 
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Figure 1. The Registry of Standard Biological Parts. This registry offers free access to basic biological functions that are used to 
create new biological systems. Pictured is a standard data sheet on a gene regulating transcription, with normal performance and 
compatibility measurements, plus an extra biological concern: system performance during evolution and cell reproduction. The 
registry is part of a conscious effort to standardize gene parts in the hopes of creating interchangeable components with well-
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device-level workers would not need to know anything 
about phosphoramidite chemistry, or genetic oscilla-
tors, etc. (Canton, 2005).
 
engineered simplicity and evolution
The rapid progress made by mechanical engineering in 
this century was made possible by creating easily under-
standable machines. Engineered simplicity is helpful 
not only for repairs but for future upgrades and rede-
signs. While a modern automobile may seem complex, 
the level of complexity pales in comparison to a living 
cell, which has far more interconnected pathways and 
interactions. Cells evolved in response to a multitude of 
evolutionary pressures and mechanisms were developed 
to be efficient, not necessarily easy to understand (Alon, 
2003). A related problem is that other engineered sys-
tems don’t evolve. Organisms such as E. coli reproduce 
and have genetic mutations within hours. While this of-
fers possibilities to the biological engineer (for instance, 
human-directed evolution for fine-tuning organism be-
havior), it also increases the complexity of designing and 
predicting the function of these new genetic systems 
(Hasteltine, 2007).
 




Researchers first raised concerns at the Asilomar Con-
ference in California during the summer of 1975 and 
concluded that current genetic experiments carried 
minimal risk. The past 30 years of experience in genet-
ically-manipulated crops demonstrated that engineered 
organisms are less fit than their wild counterparts, and 
they either die or eject their new genes without con-
stant assistance from humans. However, researchers 
concluded that the abilities to replicate and evolve re-
quired special precautions. It was recommended that all 
researchers work with bacterial strains that are specially 
designed to be metabolically deficient so they cannot 
survive in the wild. Still, some have suggested that an 
incomplete understanding and emergent properties 
arising from unforeseen interactions between new genes 
could be problematic. Such dangers have given rise to 




Research in synthetic biology may generate “dual-use” 
findings that could enable bioterrorists to develop new 
biological warfare tools that are easier to obtain and far 
more lethal than today’s military bioweapons. The most 
commonly cited example of this is the resurrection syn-
thesis of the 1918 pandemic influenza strain by CDC 
researchers (Tumpey et al, 2005) and the possibility of 
recreating smallpox from easily-ordered DNA (Venter, 
2005). There has been a growing consensus that not all 
sequences should be made publicly available, but the 
fact remains that such powerful recombinant DNA 
technologies could be used for harm.
 
Attempts to limit access to the DNA synthesis tech-
nology would be counterproductive, and a sensible ap-
proach might include some selective regulation while 
allowing research to continue. Now, as SARS, bird 
influenza, and other infectious disease emerge, these 
recombinant DNA techniques enhance our ability to 
manage this threat today compared to what was possible 
just 30 years ago. The revolution in synthetic biology is 
nothing less than a push in all fronts of biology, whether 
that impacts environmental cleanup, chemical synthesis 
using bacteria, or human health.
 
ConClusion
At present, synthetic biology’s myriad implications can 
be glimpsed only dimly. The field clearly has the poten-
tial to bring about epochal changes in medicine, agri-
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culture, industry, and politics. Some critics consider the 
idea of creating artificial organisms in the laboratory to 
be an example of scientific hubris, evocative of Faust or 
Dr. Frankenstein. However, the move from understand-
ing biology to designing it for our requirements has al-
ways been a part of the biological enterprise and used to 
produce chemicals and biopharmaceuticals. Synthetic 
biology represents an ambitious new paradigm for 
building new biosystems with rapidly increasing com-
plexity in versatility and applications. These tools for 
engineering biology are being developed and distribut-
ed, and a societal framework is needed to help not only 
create a global community that celebrates biology but 
also to lead the enormously constructive invention of 
biological technologies. 
Figure 2. Abstraction Hierarchy. Abstraction levels are important for managing complexity and are used extensively in engineering 
disciplines. As biological parts and functions become increasingly complex, writing ‘code’ with individual nucleotides is rapidly 
becoming more difficult. Currently, researchers spend considerable time learning the intricacies of every step of the process, and 
stratification would allow for specialization and faster development. Ideally, individuals can work on individual levels, one can 
focus on part design without worrying about how genetic oscillators work, while others could string together parts to construct 
whole systems for possible biosensor applications. Image originally made by Drew Endy. 
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